Literature DB >> 28418988

HIV-Specific CD8 T Cells Producing CCL-4 Are Associated With Worse Immune Reconstitution During Chronic Infection.

Rita Casetti1, Carmela Pinnetti, Alessandra Sacchi, Gabriele De Simone, Veronica Bordoni, Eleonora Cimini, Nicola Tumino, Francesca Besi, Domenico Viola, Federica Turchi, Valentina Mazzotta, Andrea Antinori, Federico Martini, Adriana Ammassari, Chiara Agrati.   

Abstract

BACKGROUND: Immunological nonresponse represents the Achilles heel in the combination antiretroviral therapy (cART) effectiveness, and increases risk of clinical events and death. CD8 T cells play a crucial role in controlling HIV replication, and polyfunctional HIV-specific CD8 T cells have been associated with nonprogressive HIV infection. However, the possible role of polyfunctional CD8 T cells in predicting posttreatment immune reconstitution has not yet been explored. The aim of this study was to identify functional markers predictive of immunological response to cART in chronic HIV-infected patients.
METHODS: A cohort of chronic HIV-infected individuals naive to cART were enrolled in the ALPHA study. CD4/CD8 T-cell subsets, their differentiation/activation, as well as susceptibility to apoptosis were analyzed before and after 12 months of cART. Moreover, CD8 T cells polyfunctional response after HIV antigenic stimulation was also assessed.
RESULTS: Results showed a significant correlation between worse CD4 T-cell restoration and low frequency of naive CD4 T cells, high frequency of effector memory CD4 T cells, and high susceptibility to apoptosis of CD4 T cells all before cART. Moreover, CD8 functional subsets expressing total C-C motif chemokine ligand 4 (CCL-4) or in combination with CD107a and interferon gamma (IFNγ) were negatively associated with immune reconstitution.
CONCLUSIONS: In conclusion, our study shows that a more differentiated phenotype of CD4 T cells and CCL-4-producing CD8 T cells could represent valuable predictors of worse immune reconstitution. These parameters may be used as tools for identifying patients at risk of immunological failure during cART and eventually represent the basis for innovative therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28418988     DOI: 10.1097/QAI.0000000000001392

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  7 in total

1.  In Human Immunodeficiency Virus primary infection, early combined antiretroviral therapy reduced γδ T-cell activation but failed to restore their polyfunctionality.

Authors:  Rita Casetti; Alessandra Sacchi; Veronica Bordoni; Germana Grassi; Eleonora Cimini; Francesca Besi; Carmela Pinnetti; Annalisa Mondi; Andrea Antinori; Chiara Agrati
Journal:  Immunology       Date:  2019-07-08       Impact factor: 7.397

2.  A Lower Baseline CD4/CD8 T-Cell Ratio Is Independently Associated with Immunodiscordant Response to Antiretroviral Therapy in HIV-Infected Subjects.

Authors:  I Rosado-Sánchez; I Herrero-Fernández; A I Álvarez-Ríos; M Genebat; M A Abad-Carrillo; E Ruiz-Mateos; F Pulido; J González-García; M Montero; E Bernal-Morell; F Vidal; M Leal; Y M Pacheco
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

3.  CCL5-Secreting Virtual Memory CD8+ T Cells Inversely Associate With Viral Reservoir Size in HIV-1-Infected Individuals on Antiretroviral Therapy.

Authors:  Wei Hu; Yan-Jun Li; Cheng Zhen; You-Yuan Wang; Hui-Huang Huang; Jun Zou; Yan-Qing Zheng; Gui-Chan Huang; Si-Run Meng; Jie-Hua Jin; Jing Li; Ming-Ju Zhou; Yu-Long Fu; Peng Zhang; Xiao-Yu Li; Tao Yang; Xiu-Wen Wang; Xiu-Han Yang; Jin-Wen Song; Xing Fan; Yan-Mei Jiao; Ruo-Nan Xu; Ji-Yuan Zhang; Chun-Bao Zhou; Jin-Hong Yuan; Lei Huang; Ya-Qin Qin; Feng-Yao Wu; Ming Shi; Fu-Sheng Wang; Chao Zhang
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

4.  Preserved immune functionality and high CMV-specific T-cell responses in HIV-infected individuals with poor CD4+ T-cell immune recovery.

Authors:  Elisabet Gómez-Mora; Elisabet García; Victor Urrea; Marta Massanella; Jordi Puig; Eugenia Negredo; Bonaventura Clotet; Julià Blanco; Cecilia Cabrera
Journal:  Sci Rep       Date:  2017-09-15       Impact factor: 4.379

Review 5.  Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders.

Authors:  Xiaodong Yang; Bin Su; Xin Zhang; Yan Liu; Hao Wu; Tong Zhang
Journal:  J Leukoc Biol       Date:  2020-01-22       Impact factor: 4.962

6.  Naïve/Effector CD4 T cell ratio as a useful predictive marker of immune reconstitution in late presenter HIV patients: A multicenter study.

Authors:  Veronica Bordoni; Bruno Brando; Pierluca Piselli; Olindo Forini; Federico Enrico Perna; Umberto Atripaldi; Sara Carputo; Federica Garziano; Elisabetta Trento; Giovanna D'Agosto; Alessandra Latini; Manuela Colafigli; Antonio Cristaudo; Alessandra Sacchi; Massimo Andreoni; Gabriella De Carli; Nicoletta Orchi; Sandro Grelli; Arianna Gatti; Carlotta Cerva; Antonella Minutolo; Marina Potestà; Maria Luisa Di Martino; Francesco Ortu; Paola Selva; Laura Del Pup; Irene Guarnori; Patrizia Lorenzini; Giusy Capuano; Andrea Antinori; Chiara Agrati
Journal:  PLoS One       Date:  2019-12-23       Impact factor: 3.240

7.  Stage-Dependent Within-Individual Comparison Reveals SIV-Specific Activation/Exhaustion Shift in Rhesus Macaques.

Authors:  Ling Tong; Zhe Cong; Long Tian; Jingjing Zhang; Jiahan Lu; Qiuhan Lu; Ting Chen; Yuhong Wang; Qiang Wei; Jing Xue
Journal:  Front Microbiol       Date:  2021-07-19       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.